Xalkori 150 mg, filmüberzogenes Granulat zum Einnehmen - 60 Swissmedic Key 69467003 Registration Holder Pfizer AG Name Xalkori 150 mg, filmüberzogenes Granulat zum Einnehmen Date of registration 29.08.2024 Introduction of Sequence 29.08.2024 ATC-Classification Crizotinib (L01ED01) Revision date WHO WHO-DDD Valid until 28.08.2029 Index Therapeuticus (BSV) Show package size 60 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680694670036 Medication Code Synthetika Pharmacode Disponibility
Composition crizotinibum 150 mg, alcohol stearylicus, poloxamerum 407, saccharum 42.86 mg, talcum, hypromellosum, macrogolum 4000, glyceroli mono/dipalmitas/stearas/oleas, triglycerida media, ad granulatum pro dosi. Packungsbestandteile Galenic Form filmüberzogenes Granulat zum Einnehmen Active Agent Dose Crizotinibum 150 mg
Inactive agents Dose Ad Granulatum pro Dosi Alcohol Stearylicus Glyceroli Mono/dipalmitas/stearas/oleas Hypromellosum Macrogol 4000 Poloxamer 407 Saccharum 42.86 mg Talcum Triglycerida Media
Source Data was imported : 05.09.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
